Literature DB >> 17690912

Genotype-phenotype correlations for SLC26A4-related deafness.

Hela Azaiez1, Tao Yang, Sai Prasad, Jessica L Sorensen, Carla J Nishimura, William J Kimberling, Richard J H Smith.   

Abstract

Pendred syndrome (PS) and non-syndromic enlarged vestibular aqueduct (EVA) are two recessive disorders characterized by the association of sensorineural hearing loss (SNHL) with inner ear malformations that range from isolated EVA to Mondini Dysplasia, a complex malformation that includes a cochlear dysplasia and EVA. Mutations in the SLC26A4 gene, coding for the protein pendrin, have been implicated in the pathophysiology of both disorders. In order to determine whether SLC26A4 genotypes can be correlated to the complexity and severity of the phenotypes, we ascertained 1,506 deaf patients. Inner ear abnormalities were present in 474 patients (32%). Mutation screening of SLC26A4 detected two mutations in 16% of patients, one mutation in 19% of patients and zero mutation in 65% of patients. When the distribution of SLC26A4 genotypes was compared across phenotypes, a statistically significant difference was found between PS patients and non-syndromic EVA-Mondini patients (P = 0.005), as well as between EVA patients and Mondini patients (P = 0.0003). There was a correlation between phenotypic complexity of inner ear malformations and genetic heterogeneity--PS patients have the most severe phenotype and the most homogeneous etiology while EVA patients have the least severe phenotype and the most heterogeneous etiology. For all patients, variability in the degree of hearing loss is seen across genotypes implicating other genetic and/or environmental factors in the pathogenesis of the PS-Mondini-EVA disease spectrum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690912     DOI: 10.1007/s00439-007-0415-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  33 in total

1.  Enlarged vestibular aqueduct: a radiological marker of pendred syndrome, and mutation of the PDS gene.

Authors:  W Reardon; C F OMahoney; R Trembath; H Jan; P D Phelps
Journal:  QJM       Date:  2000-02

2.  A deletion involving the connexin 30 gene in nonsyndromic hearing impairment.

Authors:  Ignacio del Castillo; Manuela Villamar; Miguel A Moreno-Pelayo; Francisco J del Castillo; Araceli Alvarez; Dolores Tellería; Ibis Menéndez; Felipe Moreno
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

3.  Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness.

Authors:  H-J Park; S Shaukat; X-Z Liu; S H Hahn; S Naz; M Ghosh; H-N Kim; S-K Moon; S Abe; K Tukamoto; S Riazuddin; M Kabra; R Erdenetungalag; J Radnaabazar; S Khan; A Pandya; S-I Usami; W E Nance; E R Wilcox; S Riazuddin; A J Griffith
Journal:  J Med Genet       Date:  2003-04       Impact factor: 6.318

4.  [Otitis media with effusion].

Authors:  M C Preciado; J F de la Guardia Brin
Journal:  Rev Med Panama       Date:  1986-05

5.  Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling.

Authors:  F Denoyelle; S Marlin; D Weil; L Moatti; P Chauvin; E N Garabédian; C Petit
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

6.  The large vestibular aqueduct syndrome.

Authors:  G E Valvassori; J D Clemis
Journal:  Laryngoscope       Date:  1978-05       Impact factor: 3.325

7.  Estimation of the frequency of occult mutations for an autosomal recessive disease in the presence of genetic heterogeneity: application to genetic hearing loss disorders.

Authors:  William J Kimberling
Journal:  Hum Mutat       Date:  2005-11       Impact factor: 4.878

8.  The Pendred syndrome gene encodes a chloride-iodide transport protein.

Authors:  D A Scott; R Wang; T M Kreman; V C Sheffield; L P Karniski
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

9.  Outcomes of clinical examination and genetic testing of 500 individuals with hearing loss evaluated through a genetics of hearing loss clinic.

Authors:  Dinah Yaeger; Jennifer McCallum; Kathy Lewis; Lisa Soslow; Udayan Shah; William Potsic; Catherine Stolle; Ian D Krantz
Journal:  Am J Med Genet A       Date:  2006-04-15       Impact factor: 2.802

10.  Two frequent missense mutations in Pendred syndrome.

Authors:  P Van Hauwe; L A Everett; P Coucke; D A Scott; M L Kraft; C Ris-Stalpers; C Bolder; B Otten; J J de Vijlder; N L Dietrich; A Ramesh; S C Srisailapathy; A Parving; C W Cremers; P J Willems; R J Smith; E D Green; G Van Camp
Journal:  Hum Mol Genet       Date:  1998-07       Impact factor: 6.150

View more
  30 in total

1.  Extremely discrepant mutation spectrum of SLC26A4 between Chinese patients with isolated Mondini deformity and enlarged vestibular aqueduct.

Authors:  Shasha Huang; Dongyi Han; Yongyi Yuan; Guojian Wang; Dongyang Kang; Xin Zhang; Xiaofei Yan; Xiaoxiao Meng; Min Dong; Pu Dai
Journal:  J Transl Med       Date:  2011-09-30       Impact factor: 5.531

2.  Hearing loss associated with enlarged vestibular aqueduct and zero or one mutant allele of SLC26A4.

Authors:  Jane Rose; Julie A Muskett; Kelly A King; Christopher K Zalewski; Parna Chattaraj; John A Butman; Margaret A Kenna; Wade W Chien; Carmen C Brewer; Andrew J Griffith
Journal:  Laryngoscope       Date:  2016-11-15       Impact factor: 3.325

Review 3.  Integration of human and mouse genetics reveals pendrin function in hearing and deafness.

Authors:  Amiel A Dror; Zippora Brownstein; Karen B Avraham
Journal:  Cell Physiol Biochem       Date:  2011-11-18

4.  Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss.

Authors:  Andrea M Oza; Marina T DiStefano; Sarah E Hemphill; Brandon J Cushman; Andrew R Grant; Rebecca K Siegert; Jun Shen; Alex Chapin; Nicole J Boczek; Lisa A Schimmenti; Jaclyn B Murry; Linda Hasadsri; Kiyomitsu Nara; Margaret Kenna; Kevin T Booth; Hela Azaiez; Andrew Griffith; Karen B Avraham; Hannie Kremer; Heidi L Rehm; Sami S Amr; Ahmad N Abou Tayoun
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

Review 5.  Hearing loss associated with enlargement of the vestibular aqueduct: mechanistic insights from clinical phenotypes, genotypes, and mouse models.

Authors:  Andrew J Griffith; Philine Wangemann
Journal:  Hear Res       Date:  2011-06-06       Impact factor: 3.208

6.  SLC26A4 genotype, but not cochlear radiologic structure, is correlated with hearing loss in ears with an enlarged vestibular aqueduct.

Authors:  Kelly A King; Byung Yoon Choi; Christopher Zalewski; Anne C Madeo; Ani Manichaikul; Shannon P Pryor; Anne Ferruggiaro; David Eisenman; H Jeffrey Kim; John Niparko; James Thomsen; John A Butman; Andrew J Griffith; Carmen C Brewer
Journal:  Laryngoscope       Date:  2010-02       Impact factor: 3.325

7.  SLC26A4 mutation testing for hearing loss associated with enlargement of the vestibular aqueduct.

Authors:  Taku Ito; Julie Muskett; Parna Chattaraj; Byung Yoon Choi; Kyu Yup Lee; Christopher K Zalewski; Kelly A King; Xiangming Li; Philine Wangemann; Thomas Shawker; Carmen C Brewer; Seth L Alper; Andrew J Griffith
Journal:  World J Otorhinolaryngol       Date:  2013-05-28

Review 8.  Human hereditary hearing impairment: mouse models can help to solve the puzzle.

Authors:  Karen Vrijens; Lut Van Laer; Guy Van Camp
Journal:  Hum Genet       Date:  2008-09-11       Impact factor: 4.132

9.  Segregation of enlarged vestibular aqueducts in families with non-diagnostic SLC26A4 genotypes.

Authors:  B Y Choi; A C Madeo; K A King; C K Zalewski; S P Pryor; J A Muskett; W E Nance; J A Butman; C C Brewer; A J Griffith
Journal:  J Med Genet       Date:  2009-07-02       Impact factor: 6.318

10.  Mutations of KCNJ10 together with mutations of SLC26A4 cause digenic nonsyndromic hearing loss associated with enlarged vestibular aqueduct syndrome.

Authors:  Tao Yang; Jose G Gurrola; Hao Wu; Sui M Chiu; Philine Wangemann; Peter M Snyder; Richard J H Smith
Journal:  Am J Hum Genet       Date:  2009-05-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.